436 related articles for article (PubMed ID: 11121466)
1. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors.
Chenevert TL; Stegman LD; Taylor JM; Robertson PL; Greenberg HS; Rehemtulla A; Ross BD
J Natl Cancer Inst; 2000 Dec; 92(24):2029-36. PubMed ID: 11121466
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic efficacy of DTI-015 using diffusion magnetic resonance imaging as an early surrogate marker.
Hall DE; Moffat BA; Stojanovska J; Johnson TD; Li Z; Hamstra DA; Rehemtulla A; Chenevert TL; Carter J; Pietronigro D; Ross BD
Clin Cancer Res; 2004 Dec; 10(23):7852-9. PubMed ID: 15585617
[TBL] [Abstract][Full Text] [Related]
3. Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging.
Chenevert TL; McKeever PE; Ross BD
Clin Cancer Res; 1997 Sep; 3(9):1457-66. PubMed ID: 9815831
[TBL] [Abstract][Full Text] [Related]
4. Predicting and monitoring response to chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea in subcutaneously implanted 9L glioma using the apparent diffusion coefficient of water and 23Na MRI.
Babsky AM; Hekmatyar SK; Zhang H; Solomon JL; Bansal N
J Magn Reson Imaging; 2006 Jul; 24(1):132-9. PubMed ID: 16758478
[TBL] [Abstract][Full Text] [Related]
5. Growth kinetics and treatment response of the intracerebral rat 9L brain tumor model: a quantitative in vivo study using magnetic resonance imaging.
Kim B; Chenevert TL; Ross BD
Clin Cancer Res; 1995 Jun; 1(6):643-50. PubMed ID: 9816027
[TBL] [Abstract][Full Text] [Related]
6. Earlier detection of tumor treatment response using magnetic resonance diffusion imaging with oscillating gradients.
Colvin DC; Loveless ME; Does MD; Yue Z; Yankeelov TE; Gore JC
Magn Reson Imaging; 2011 Apr; 29(3):315-23. PubMed ID: 21190804
[TBL] [Abstract][Full Text] [Related]
7. Dynamic imaging of emerging resistance during cancer therapy.
Lee KC; Hall DE; Hoff BA; Moffat BA; Sharma S; Chenevert TL; Meyer CR; Leopold WR; Johnson TD; Mazurchuk RV; Rehemtulla A; Ross BD
Cancer Res; 2006 May; 66(9):4687-92. PubMed ID: 16651420
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of (E)-2'-deoxy-2'-(fluoromethylene)cytidine on the 9L rat brain tumor model using MRI.
Ross BD; Chenevert TL; Garwood M; Kim B; Stegman LD; Ben-Yoseph O; Zwolshen J; Rehemtulla A; Sunkara PS
NMR Biomed; 2003 Apr; 16(2):67-76. PubMed ID: 12730947
[TBL] [Abstract][Full Text] [Related]
9. The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome.
Moffat BA; Chenevert TL; Meyer CR; McKeever PE; Hall DE; Hoff BA; Johnson TD; Rehemtulla A; Ross BD
Neoplasia; 2006 Apr; 8(4):259-67. PubMed ID: 16756718
[TBL] [Abstract][Full Text] [Related]
10. Intratumoral injection of BCNU in ethanol (DTI-015) results in enhanced delivery to tumor--a pharmacokinetic study.
Hamstra DA; Moffat BA; Hall DE; Young JM; Desmond TJ; Carter J; Pietronigro D; Frey KA; Rehemtulla A; Ross BD
J Neurooncol; 2005 Jul; 73(3):225-38. PubMed ID: 15980973
[TBL] [Abstract][Full Text] [Related]
11. Proton and sodium MRI assessment of emerging tumor chemotherapeutic resistance.
Schepkin VD; Lee KC; Kuszpit K; Muthuswami M; Johnson TD; Chenevert TL; Rehemtulla A; Ross BD
NMR Biomed; 2006 Dec; 19(8):1035-42. PubMed ID: 16894643
[TBL] [Abstract][Full Text] [Related]
12. Laboratory studies of berberine used alone and in combination with 1,3-bis(2-chloroethyl)-1-nitrosourea to treat malignant brain tumors.
Zhang RX; Dougherty DV; Rosenblum ML
Chin Med J (Engl); 1990 Aug; 103(8):658-65. PubMed ID: 2122945
[TBL] [Abstract][Full Text] [Related]
13. Sodium magnetic resonance imaging of chemotherapeutic response in a rat glioma.
Schepkin VD; Ross BD; Chenevert TL; Rehemtulla A; Sharma S; Kumar M; Stojanovska J
Magn Reson Med; 2005 Jan; 53(1):85-92. PubMed ID: 15690506
[TBL] [Abstract][Full Text] [Related]
14. The sequential changes in DNA synthesis, glucose utilization, protein synthesis, and peripheral benzodiazepine receptor density in C6 brain tumors after chemotherapy to predict the response of tumors to chemotherapy.
Takeda N; Diksic M; Yamamoto YL
Cancer; 1996 Mar; 77(6):1167-79. PubMed ID: 8635140
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of serial changes on computed tomography and magnetic resonance imaging after implantation of carmustine wafers in patients with malignant gliomas for differential diagnosis of tumor recurrence.
Ohue S; Kohno S; Inoue A; Yamashita D; Suehiro S; Seno T; Kumon Y; Kikuchi K; Ohnishi T
J Neurooncol; 2016 Jan; 126(1):119-126. PubMed ID: 26384812
[TBL] [Abstract][Full Text] [Related]
16. Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging.
Rehemtulla A; Stegman LD; Cardozo SJ; Gupta S; Hall DE; Contag CH; Ross BD
Neoplasia; 2000; 2(6):491-5. PubMed ID: 11228541
[TBL] [Abstract][Full Text] [Related]
17. The surgical bed after BCNU polymer wafer placement for recurrent glioma: serial assessment on CT and MR imaging.
Hammoud DA; Belden CJ; Ho AC; Dal Pan GJ; Herskovits EH; Hilt DC; Brem H; Pomper MG
AJR Am J Roentgenol; 2003 May; 180(5):1469-75. PubMed ID: 12704070
[TBL] [Abstract][Full Text] [Related]
18. Concurrent treatment with BCNU and Gamma Knife radiosurgery in the rat malignant glioma model.
Cho KT; Kim DG; Paek SH; Chung HT; Jung HW; Park HW
J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):132-41. PubMed ID: 22628080
[TBL] [Abstract][Full Text] [Related]
19. Invasive phenotype observed in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant sublines of 9L rat glioma cells: a tumor model mimicking a recurrent malignant glioma.
Saito R; Bringas J; Mirek H; Berger MS; Bankiewicz KS
J Neurosurg; 2004 Nov; 101(5):826-31. PubMed ID: 15540922
[TBL] [Abstract][Full Text] [Related]
20. In vivo magnetic resonance imaging of sodium and diffusion in rat glioma at 21.1 T.
Schepkin VD; Bejarano FC; Morgan T; Gower-Winter S; Ozambela M; Levenson CW
Magn Reson Med; 2012 Apr; 67(4):1159-66. PubMed ID: 21748798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
